Funded Startups in Southlake
Among the eight most recent disclosed rounds tied to Southlake, Texas, Renibus Therapeutics’ $25M Series B (2023-09-12) is the largest disclosed amount, an…
Among the eight most recent disclosed rounds tied to Southlake, Texas, Renibus Therapeutics’ $25M Series B (2023-09-12) is the largest disclosed amount, and it sits above the next-largest $18M Onconano Medicine Series B (2021-10-25). The rest of the disclosed rounds cluster mostly below $10M, with multiple “small” financings at $2M (Mindzie, 2021-01-05) and $980K/$500K levels (Profit on 2023-06-01 for $980K; ARTFLLY and truMED on 2021-04-15 and 2021-04-14 for $500K each).
Sector and timing concentrate: biotech appears in 4 of 8 entries (Renibus Therapeutics; Onconano Medicine twice), while 5 of 8 rounds are labeled “Seed” or “Series B” between 2021-01-05 and 2023-09-12. Dates span 2021-01-05 (Mindzie) through 2023-09-12 (Renibus Therapeutics), and the newest entry is the Renibus Therapeutics $25M round on 2023-09-12. Financial Services and Biotechnology both show up multiple times, and one notable outlier is Renegade Insurance’s $75M “Venture - Series Unknown” round on 2022-04-03, which dwarfs the next-highest disclosed amount in this view.
Most recent rounds
8 shownRelated listings
Frequently asked
What’s the largest disclosed round for Southlake in this list, and how does it compare with the rest?
Renegade Insurance has the largest disclosed amount at $75M on 2022-04-03 (“Venture - Series Unknown”). In contrast, the next-largest disclosed amount is $25M for Renibus Therapeutics on 2023-09-12, with most other disclosed rounds landing well below $10M (for example, Profit at $980K on 2023-06-01; Mindzie at $2M on 2021-01-05).
Do multiple sectors over-represent in these eight Southlake entries?
Yes. Biotech accounts for 4 of 8 entries, driven by Renibus Therapeutics and Onconano Medicine (two separate rounds on 2021-10-25 for $18M and 2021-06-17 for $50M). Financial Services also appears in 2 of 8 entries (Profit at $980K on 2023-06-01 and Renegade Insurance at $75M on 2022-04-03), while the remaining sectors (AI, IT, commerce) appear once each.
Is there a timing cluster, or are rounds spread evenly across years?
They’re concentrated within a roughly 2.7-year window: the oldest shown round is Mindzie on 2021-01-05 ($2M) and the newest is Renibus Therapeutics on 2023-09-12 ($25M). There’s also a dense 2021 cluster where several seed rounds land in April 2021 (ARTFLLY on 2021-04-15 for $500K; truMED on 2021-04-14 for $500K) and Onconano Medicine runs in June and October 2021 ($50M on 2021-06-17 and $18M on 2021-10-25).
What stage mix dominates this snapshot of Southlake funding?
Seed rounds are prominent at 3 of 8 entries (Profit is Seed on 2023-06-01 for $980K; ARTFLLY is Seed on 2021-04-15 for $500K; truMED is Seed on 2021-04-14 for $500K). Series B appears 2 of 8 entries (Renibus Therapeutics at $25M on 2023-09-12; Onconano Medicine at $18M on 2021-10-25), and “Venture - Series Unknown” appears once (Renegade Insurance, $75M on 2022-04-03). One Onconano Medicine row is missing a stage label (2021-06-17, $50M).
Are there outliers in sector or round size worth investigating further?
The largest-size outlier is Renegade Insurance’s $75M on 2022-04-03, labeled “Venture - Series Unknown,” which is far above the other disclosed highs in this view (e.g., $25M on 2023-09-12 and $18M on 2021-10-25). On the low end, the smallest disclosed amount is Mindzie at $2M on 2021-01-05, below Profit’s $980K Seed on 2023-06-01 and the $500K seed rounds for ARTFLLY (2021-04-15) and truMED (2021-04-14).
Which entries fall closest to the most recent date shown in Southlake, Texas?
Using the newest round date (2023-09-12, Renibus Therapeutics at $25M), the next-closest in time is Profit’s Seed on 2023-06-01 for $980K. The remaining entries jump back to 2022-04-03 (Renegade Insurance, $75M) and then 2021 dates, including multiple Onconano Medicine rounds in 2021 ($50M on 2021-06-17 and $18M on 2021-10-25) and April 2021 seed rounds for ARTFLLY ($500K) and truMED ($500K).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.